139 related articles for article (PubMed ID: 37269621)
1. Role of Early Intravenous Immunoglobulins in Halting Clinical and Radiographic Disease Progression in Rasmussen Encephalitis.
Jaafar F; Obeid M; Beydoun A
Pediatr Neurol; 2023 Aug; 145():30-35. PubMed ID: 37269621
[TBL] [Abstract][Full Text] [Related]
2. The Important Role of Hemispherotomy for Rasmussen Encephalitis: Clinical and Functional Outcomes.
Thomé U; Batista LA; Rocha RP; Terra VC; Hamad APA; Sakamoto AC; Santos AC; Santos MV; Machado HR
Pediatr Neurol; 2024 Jan; 150():82-90. PubMed ID: 37992429
[TBL] [Abstract][Full Text] [Related]
3. Rasmussen encephalitis: long-term outcome after surgery.
Terra-Bustamante VC; Machado HR; dos Santos Oliveira R; Serafini LN; Souza-Oliveira C; Escorsi-Rosset S; Yacubian EM; Naffah-Mazzacoratti Mda G; Scorza CA; Cavalheiro EA; Scorza FA; Sakamoto AC
Childs Nerv Syst; 2009 May; 25(5):583-9. PubMed ID: 19153752
[TBL] [Abstract][Full Text] [Related]
4. Long-term seizure outcome and mobility after surgical treatment for Rasmussen encephalitis in children: A single-center experience.
Nava BC; Costa UT; Hamad APA; Garcia CAB; Sakamoto AC; Aragon DC; Machado HR; Santos MV
Epileptic Disord; 2023 Oct; 25(5):749-757. PubMed ID: 37589547
[TBL] [Abstract][Full Text] [Related]
5. Rasmussen encephalitis with active inflammation and delayed seizures onset.
Korn-Lubetzki I; Bien CG; Bauer J; Gomori M; Wiendl H; Trajo L; Ovadia H; Wilken B; Hans VH; Elger CE; Hurvitz H; Steiner I
Neurology; 2004 Mar; 62(6):984-6. PubMed ID: 15037707
[TBL] [Abstract][Full Text] [Related]
6. Medical treatment of Rasmussen's Encephalitis: A systematic review.
Lagarde S; Boucraut J; Bartolomei F
Rev Neurol (Paris); 2022 Sep; 178(7):675-691. PubMed ID: 35131107
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory therapy versus surgery for Rasmussen syndrome in early childhood.
Takahashi Y; Yamazaki E; Mine J; Kubota Y; Imai K; Mogami Y; Baba K; Matsuda K; Oguni H; Sugai K; Ohtsuka Y; Fujiwara T; Inoue Y
Brain Dev; 2013 Sep; 35(8):778-85. PubMed ID: 23433490
[TBL] [Abstract][Full Text] [Related]
8. Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins.
Bien CG; Tiemeier H; Sassen R; Kuczaty S; Urbach H; von Lehe M; Becker AJ; Bast T; Herkenrath P; Karenfort M; Kruse B; Kurlemann G; Rona S; Schubert-Bast S; Vieker S; Vlaho S; Wilken B; Elger CE
Epilepsia; 2013 Mar; 54(3):543-50. PubMed ID: 23216622
[TBL] [Abstract][Full Text] [Related]
9. Clinical Applications of Intravenous Immunoglobulins in Child Neurology.
Gogou M; Papadopoulou-Alataki E; Spilioti M; Alataki S; Evangeliou A
Curr Pharm Biotechnol; 2017 Nov; 18(8):628-637. PubMed ID: 28914199
[TBL] [Abstract][Full Text] [Related]
10. Seizure Outcomes and Reoperation in Surgical Rasmussen Encephalitis Patients.
Sundar SJ; Lu E; Schmidt ES; Kondylis ED; Vegh D; Poturalski MJ; Bulacio JC; Jehi L; Gupta A; Wyllie E; Bingaman WE
Neurosurgery; 2022 Jul; 91(1):93-102. PubMed ID: 35544031
[TBL] [Abstract][Full Text] [Related]
11. Parry-Romberg syndrome and Rasmussen encephalitis: possible association. Clinical and neuroimaging features.
Longo D; Paonessa A; Specchio N; Delfino LN; Claps D; Fusco L; Randisi F; Genovese E; Vigevano F; Fariello G
J Neuroimaging; 2011 Apr; 21(2):188-93. PubMed ID: 19555404
[TBL] [Abstract][Full Text] [Related]
12. Clinical application and evaluation of the Bien diagnostic criteria for Rasmussen encephalitis.
Olson HE; Lechpammer M; Prabhu SP; Ciarlini PD; Poduri A; Gooty VD; Anjum MW; Gorman MP; Loddenkemper T
Epilepsia; 2013 Oct; 54(10):1753-60. PubMed ID: 23980696
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of rituximab in a case with late-onset Rasmussen´s encephalitis with anti-ganglioside IgGQ1b and anti-GAD antibodies positivity. Case Report.
Timarova G; Lisa I; Kukumberg P
Neuro Endocrinol Lett; 2016 Jul; 37(3):179-183. PubMed ID: 27618602
[TBL] [Abstract][Full Text] [Related]
14. Rasmussen encephalitis in childhood.
Topçu M; Turanli G; Aynaci FM; Yalnizoglu D; Saatçi I; Yigit A; Genç D; Söylemezoglu F; Bertan V; Akalin N
Childs Nerv Syst; 1999 Aug; 15(8):395-402; discussion 403. PubMed ID: 10447611
[TBL] [Abstract][Full Text] [Related]
15. Hemispherotomy in Rasmussen encephalitis: long-term outcome in an Italian series of 16 patients.
Granata T; Matricardi S; Ragona F; Freri E; Casazza M; Villani F; Deleo F; Tringali G; Gobbi G; Tassi L; Lo Russo G; Marras CE; Specchio N; Vigevano F; Fusco L
Epilepsy Res; 2014 Aug; 108(6):1106-19. PubMed ID: 24815913
[TBL] [Abstract][Full Text] [Related]
16. Bilateral Rasmussen Encephalitis: Good Outcome Following Hemispherotomy.
Trapp N; Co DO; Rebsamen S; Ikonomidou C; Ahmed R; Knox A
Pediatr Neurol; 2024 Feb; 151():1-4. PubMed ID: 38041904
[TBL] [Abstract][Full Text] [Related]
17. Early add-on immunoglobulin administration in Rasmussen encephalitis: the hypothesis of neuroimmunomodulation.
Papetti L; Nicita F; Granata T; Guerrini R; Ursitti F; Properzi E; Iannetti P; Spalice A
Med Hypotheses; 2011 Nov; 77(5):917-20. PubMed ID: 21885203
[TBL] [Abstract][Full Text] [Related]
18. Rethinking the Magnetic Resonance Imaging Findings in Early Rasmussen Encephalitis: A Case Report and Review of the Literature.
Holec M; Nagahama Y; Kovach C; Joshi C
Pediatr Neurol; 2016 Jun; 59():85-9. PubMed ID: 27004940
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: An open pilot study.
Lagarde S; Villeneuve N; Trébuchon A; Kaphan E; Lepine A; McGonigal A; Roubertie A; Barthez MA; Trommsdorff V; Lefranc J; Wehbi S; des Portes V; Laguitton V; Quartier P; Scavarda D; Giusiano B; Milh M; Bulteau C; Bartolomei F
Epilepsia; 2016 Jun; 57(6):956-66. PubMed ID: 27106864
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatment of patients with Rasmussen encephalitis.
Guan Y; Zhou J; Luan G; Liu X
Stereotact Funct Neurosurg; 2014; 92(2):86-93. PubMed ID: 24503650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
